Stockreport

GeneDx Expands Commercial Footprint for Exome and Genome Testing with Inborn Errors of Immunity as a New Indication [Yahoo! Finance]

Opko Health, Inc.  (OPK) 
Last opko health, inc. earnings: 2/26 04:05 pm Check Earnings Report
US:NYSE Investor Relations: investor.opko.com
PDF and opens new opportunities for GeneDx and biopharma partners to accelerate the path to treatment for patients GAITHERSBURG, Md., April 03, 2025 BUSINESS WIRE )--GeneD [Read more]